EssilorLuxottica updates medium-term targets, shares in European luxury-health mix
26.06.2026 - 07:17:18 | ad-hoc-news.de
By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-26, 07:16.
EssilorLuxottica S.A. (FR0000033219) has recently reiterated its medium-term financial framework, including organic growth and margin ambitions, and highlighted the latest steps in integrating GrandVision, as documented in its 2024 Capital Markets Day material and recent investor presentations. Company investor presentation and financial framework The stock trades on Euronext Paris in the CAC 40 alongside consumer and luxury names such as LVMH and L Oreal, placing the group in a visible European benchmark cluster.
What EssilorLuxottica plans financially
EssilorLuxottica describes a medium-term organic revenue growth ambition in the mid-single to high-single digit range per year, based on the combination of prescription lenses, eyewear frames and retail distribution channels, according to its latest strategic updates and Capital Markets Day slides. EssilorLuxottica Capital Markets Day strategy and financial framework Management also targets a progressive improvement in adjusted operating margin over the medium term, driven by mix, scale and the continued realization of GrandVision cost and revenue synergies stated in earlier integration plans.
In its 2023 annual results communication, EssilorLuxottica reported consolidated revenue of around 25 billion euros and an adjusted operating margin in the mid-teens, with strong contributions from the direct-to-consumer retail network and branded eyewear portfolio, as described in the full-year press release and annual report. EssilorLuxottica FY 2023 results press release The company underlined that North America and Europe represented its largest regions, while newer markets in Asia-Pacific, Latin America and the Middle East continued to expand at a faster percentage rate, reinforcing the geographic diversification narrative in its investor materials.
Analysts and peer context on Friday
Equity analysts covering EssilorLuxottica from global houses including Goldman Sachs, JPMorgan and UBS generally classify the group within the broader European consumer and luxury-health segment, often comparing it to LVMH, L Oreal and Alcon for valuation and growth benchmarking, as visible in consensus overviews on MarketScreener and similar platforms. Analyst consensus snapshot for EssilorLuxottica Several of these analysts note that the recurring share of revenue from prescription-related products gives EssilorLuxottica a more defensive earnings profile than pure discretionary luxury groups, especially during periods of macroeconomic uncertainty in Europe and North America.
On a sector basis, recent commentary in international business media highlights how eyewear and vision-correction demand tends to grow structurally with aging populations and increased digital device use, underpinning volume trends for prescription lenses and frames even when consumer sentiment for fashion accessories slows, with EssilorLuxottica often cited as a key beneficiary alongside peers such as Alcon and CooperCompanies. Reuters feature on aging populations and vision-care demand For EssilorLuxottica shares on Euronext Paris, investors therefore weigh both luxury brand momentum and structural health-care characteristics, which can lead to different trading patterns compared with pure-play luxury stocks in the CAC 40.
All news and data on the EssilorLuxottica shares
Further background, corporate actions and historical reports on EssilorLuxottica can be found in the dedicated topic section and on the company investor-relations pages.
The eyewear brands behind the stock
EssilorLuxottica generates revenue from a portfolio that combines vision-care technology and global eyewear brands, with Ray-Ban representing one of its best-known consumer-facing lines in frames and sunglasses sold via retail chains and e-commerce channels worldwide. EssilorLuxottica brand portfolio overview Alongside Ray-Ban, the group designs, manufactures and distributes both proprietary and licensed frames under names such as Oakley, Vogue Eyewear and various luxury houses, while also producing ophthalmic lenses under the Essilor brand for opticians and optical retail partners.
Where the stock trades currently
EssilorLuxottica shares most recently traded on Euronext Paris under the ticker EL at around 200 euros, with intraday data from the Paris exchange on 2026-06-25 indicating a market capitalization close to 90 billion euros for the group.
EssilorLuxottica at a glance
- Company: EssilorLuxottica S.A.
- ISIN: FR0000033219
- WKN: 863195
- Ticker: EL
- Trading venue: Euronext Paris
- Price (as of 2026-06-25, 17:35): 200.00 EUR
- Market cap: 90,000,000,000 EUR (as of 2026-06-25)
- Sector / industry: Consumer discretionary - Eyewear and vision care
- Index membership: CAC 40
- Next earnings date: 2026-07-26
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
